← Back to Search

MISSION-CJ Program for Substance Abuse and Mental Health Issues in Homeless Veterans (MISSION-CJ Trial)

N/A
Recruiting
Led By Daniel M. Blonigen, PhD MA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
The only exclusion criterion is being too cognitively impaired to understand the informed-consent process and other study procedures.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-month period prior to, and ending 15 months after, study enrollment
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether the MISSION-CJ program can help Veterans with substance abuse and mental health problems to stay out of jail and improve their overall health.

Who is the study for?
This trial is for homeless veterans who have recently been in legal trouble, are about to enter a mental health program, and struggle with both substance use and mental health disorders. Veterans must be able to understand the study's consent process.
What is being tested?
The MISSION-CJ program aims to help these veterans by reducing criminal behavior and improving their overall well-being, including substance use, mental health status, housing stability, employment opportunities, and community involvement.
What are the potential side effects?
Since this intervention involves support services rather than medication, there aren't typical medical side effects. However, participants may experience emotional or social discomfort as they engage with the program.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I understand the consent process and study procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-month period prior to, and ending 15 months after, study enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-month period prior to, and ending 15 months after, study enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Criminal Recidivism
Criminal recidivism
Secondary study objectives
Change in Affiliations with Antisocial Peers (Measures of Criminal Attitudes and Associates ? MCAA)
Change in Antisocial Attitudes (Measures of Criminal Attitudes and Associates - MCAA)
Change in Community Integration Measure (CIM)
+14 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: MISSION-CJExperimental Treatment1 Intervention
Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice version (MISSION-CJ) programming targets co-occurring substance use and mental health disorders and other related health outcomes faced by justice-involved homeless Veterans through assertive outreach, psychoeducation, and linkages to community-based services.
Group II: Enhanced Usual CareExperimental Treatment1 Intervention
Usual care provided by the mental health residential rehabilitation treatment programs, with patients in both groups are enrolled in, in addition to peer support and community outreach case management. Patients receive 2 Peer Support Curriculum sessions per week (24 sessions total). Patients will receive unstructured community outreach and linkage support while enrolled in the mental health residential rehabilitation program. After discharge, patients will continue to receive 1 hour of weekly linkage support per week.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,663 Previous Clinical Trials
3,427,138 Total Patients Enrolled
Daniel M. Blonigen, PhD MAPrincipal InvestigatorVA Palo Alto Health Care System, Palo Alto, CA
3 Previous Clinical Trials
838 Total Patients Enrolled
David A. Smelson, PsyDPrincipal InvestigatorVA Bedford HealthCare System, Bedford, MA
4 Previous Clinical Trials
657 Total Patients Enrolled

Media Library

Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice Clinical Trial Eligibility Overview. Trial Name: NCT04523337 — N/A
Mental Health Disorders Research Study Groups: Enhanced Usual Care, MISSION-CJ
Mental Health Disorders Clinical Trial 2023: Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice Highlights & Side Effects. Trial Name: NCT04523337 — N/A
Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice 2023 Treatment Timeline for Medical Study. Trial Name: NCT04523337 — N/A
~10 spots leftby Feb 2025